SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Reefer Token

REEFER Token is gaining attention as discussions revolve around its utility within the cannabis industry, including CBD product availability and acceptance at dispensaries. Community members are actively sharing updates on listings, partnerships, and developments related to the token's ecosystem. Some users are also speculating on the potential impact of cannabis legalization on the crypto.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

"Crow with knife" ($CAW) is trending, driven by strong community support and multi-chain expansion across networks like Solana and Base. The coin's deflationary mechanisms and organic growth are key talking points, with supporters emphasizing its potential to outperform other meme coins. The community is actively coordinating buys across chains and promoting the project's unique narrative.

Signet Jewelers Ltd. engages in the retail of diamond jewelry. It operates through the following business segments: North America, International, and Others. The North America segment operates jewelry stores in malls, mall-based kiosks, and off-mall locations throughout the U.S. and Canada. The International segment sells primarily in the UK and Ireland under the H. Samuel and Ernest Jones banners. The Other segment consists of activities related to purchasing and conversion of rough diamonds to polished stones and unallocated corporate administrative functions. The company was founded in 1949 and is headquartered in Hamilton, Bermuda.

Signet Jewelers Ltd

Signet Jewelers is trending due to positive Q2 results, including same-store sales growth and margin expansion, leading to an increased FY26 outlook that has analysts updating their ratings. Community members are also discussing the company's strategic shift towards lab-grown diamonds, which is driving growth and profitability. Options activity suggests bearish sentiment, with some traders highlighting unusual call flow and sweep call trades.

Hydrex is the MetaDEX & Liquidity Infrastructure purpose-built for Base. By combining automated strategies, liquid-backed tokenomics, and Base's powerful distribution channels, Hydrex removes the barriers to yield. It's designed as a coordination system where weekly community governance directs HYDX emissions & protocol revenue. Value flows to where liquidity and volume are most productive, based on protocol alignment.

Hydrex

Hydrex ($HYDX) is trending as a potential competitor to $AERO, with community members highlighting recent whale buys and a significant weekly chart increase. Discussion centers on its position as a Base runner with a low market cap and unique tokenomics, including locked team allocations and strategic protocol reserves. Some users are speculating about a potential Coinbase listing due to high social media activity.

Nucor Corp. engages in the manufacture of steel products, and ferrous and non-ferrous materials. It operates through the following segments: Steel Mills, Steel Products, and Raw Materials. The Steel Mills segment consists of producing sheet, plate, structural, and bar steel. The Steel Products segment includes steel joists and joist girders, deck, fabricated concrete reinforcing, cold finished, fasteners, metal building systems, grating, tubular, piling products businesses, and wire mesh. The Raw Materials segment consists of direct reduced iron, and ferrous and nonferrous metals. The company was founded by Ransom E. Olds in 1905 and is headquartered in Charlotte, NC.

Nucor Corp.

Nucor ($NUE) is trending amid discussions around potential benefits from tariffs under a possible new Trump administration, with community members pointing to the company's position as America's largest steel producer. Some investors see the recent price drop as a buying opportunity, while others express concerns about declining earnings and broader economic uncertainty. Options activity and analyst ratings are also contributing to the heightened interest in the stock.

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Niagen Bioscience Inc.

Niagen Bioscience Inc. is trending as investors discuss its potential growth, particularly following discussions of a study, alongside concerns of a recent dip. The company's fundamentals, including revenue growth and ongoing clinical trials (such as Parkinson's and Long COVID), are key talking points, while recent analyst ratings are also impacting sentiment. Community members are weighing the potential impact of increasing sales and sales partnerships.

BlackRock Institutional Trust Company N.A. - iShares Biotechnology ETF

iShares Biotechnology ETF

IBB is trending as the biotech sector gains momentum, with discussions focusing on consistent accumulation and potential breakouts. Community members are highlighting unusual options activity with bullish sentiment and accumulation above key moving averages. Positive analyst ratings for individual biotech companies within the ETF, along with expansion in the biosimilar market, may be contributing to the increased interest.

Base Protocol (BASE) is a token whose price is pegged to the total market cap of all cryptocurrencies at a ratio of 1 : 1 trillion. BASE allows traders to speculate on the entire crypto industry with one token. If crypto market cap is $450B, BASE is $0.45. If crypto market cap is $800B, BASE is $0.80.

B3 (BASE) is trending due to its recent listing on Coinbase and growing excitement surrounding its gaming ecosystem. Community members are actively discussing the potential for B3 to become a leading platform for on-chain gaming, drawing comparisons to other successful projects. The overall positive sentiment suggests growing interest in the Base network and its potential for future growth.

Based Chad

Based Chad is trending as community members highlight its availability on Coinbase's DEX integration and its strong meme culture. Conversations revolve around its potential for growth, partnerships, and upcoming video game. The community emphasizes its strong meme recognition and organic presence, encouraging others to join.

Pump.fun

Pump.fun is currently trending as the community rallies around the platform and related tokens on Solana, with many highlighting a sense of community and shared success using the hashtag $WAGMI. Community members are actively discussing potential breakouts and long-term potential. A common theme revolves around community support and the potential for significant gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Align Technology (ALGN) Up 9.4% Since Last Earnings Report?

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Bear of the Day: Align Technology (ALGN)

Growth outlook continues to disappoint for clear "smile straightener," but CEO thinks his shares are on sale

Modine Manufacturing and Align Technology have been highlighted as Zacks Bull and Bear of the Day

Modine lifts 2026 guidance after strong Q1 and $100M data center expansion, while Align sinks on weak Q2 results and forecast cuts.

Is Align Technology (ALGN) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Align Technology (ALGN) Loses 34.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Align Technology (ALGN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

SYK Stock Falls Despite Q2 Earnings & Sales Beat, '25 View Up

SYK's second-quarter results reflect strong segmental performance, along with a rise in operating margin.

BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down

Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.

DexCom Stock Falls Despite Q2 Earnings Beat & 2025 Sales View Raise

DXCM beats on Q2 earnings and raises 2025 sales guidance, but shares dip as margin pressure dampens investor enthusiasm.

ALGN Stock Falls on Q2 Earnings and Revenue Miss, Margins Down

Align Technology tumbles 34.2% after Q2 earnings and revenues miss estimates as Clear Aligner sales drop and margins tighten further.

Align Technology (ALGN) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad’s CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Align Technology, Inc.

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$132.17
Prev Close	$128.70
Open	$129.73
Dividend Yield	0.00%
50-Day Moving Average	$141.47
Beta	1.56
Avg. Volume	1.28M
PE Ratio	22.30

52-Week High	$246.19
52-Week Low	$122.00
Market Capitalization	$9.58B
EPS (Annual)	$5.62
Price to Book	2.45
Revenue Per Employee	$190,929.20
Enterprise Value/EBITDA	N/A

ALGN
Align Technology, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALGN News

ALGN Align Technology, Inc.